Replies to post #112437 on Amarin Corp Plc (AMRN)

[couldbebetter]

BB, I do not think the FDA will attempt to punish AMRN. My view is that it may not matter because I believe that once the complete set of reslts from R-I are out, BP will be able to use the info to consider a bid for the company. Certainly, if the results were good and the FDA were not forthcoming, management would be more compelled to sell the company.

[shadolane]

Sorry to say but I'm not knowledgeable in this field.

Is what you are saying that successful R-I will be of no consequence to AMRN and its pps?

Please explain the implications.

Thanks

[sts66]

There's justified skepticism the FDA will not work with Amarin to ever approve another label for Vascepa ever. This is directly based on the actions the FDA has taken in the past.

And it doesn't help our cause or the pps when AMRN specifically points that out in a CC as rationale for shelving development of AMR-102, essentially saying "we don't trust the FDA".